CBRS · Cerebras Systems Inc. · Metrics
Market Cap
$44.22B
Shares
237.56M
CBRS metrics
36 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$198.37
Market cap
$44.22B
Price action
20 metricsPrice change (1W)
+3.4%
Price change (30D)
+1.1%
Price change (3M)
-15.5%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
121.6%
Annualized volatility (3M)
122.4%
Beta
—
RSI (14D)
50.8
Price vs SMA 50
-1.6%
Price vs SMA 200
—
Avg volume (3M)
7.13M
Relative volume
1.5
Average dollar volume
$1.45B
Company
3 metricsSector
Technology
Industry
Semiconductors
Shares outstanding
237.56M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
4.8
reciprocal yield 20.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+74.3%
Year over year
Net income growth YoY
-245.6%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-256.0%
Shares change YoY
-6.7%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
0.1
Current ratio
5.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
5.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$5.82B
Latest balance sheet
Cash & equivalents
$6.74B
Total assets
$11.63B
Total debt
$918.24M
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
422
13F filer change QoQ
+422
Institutional ownership
41.4%
Short interest
3 metricsShort interest
5.6%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
52 / 100
Insider activity
2 metricsNet insider buying (90D)
−$295.59M
Insider-sentiment score
5 / 100
Risk flags
1 metricsGoing concern
—